PFECongressional Stock Trades
Pfizer Inc.
Pharmaceutical Preparations
Congressional stock trades in Pfizer Inc. (PFE) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
29
Politicians Trading
15
Last Traded
Jul 7, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Alan ArmstrongR | Jul 21, 2026 | Mar 24, 2026 | Sell | $50,001 - $100,000 | +11.28% |
| Tommy TubervilleR | Jul 16, 2026 | Jun 8, 2026 | Sell | $15,001 - $50,000 | +17.10% |
| John BoozmanR | Mar 6, 2025 | Feb 13, 2025 | Sell | $1,001 - $15,000 | +17.00% |
Price History
About Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
15 members of Congress have disclosed 29 trades in Pfizer Inc. (PFE). Most active: Gilbert Ray Cisneros, Jr. (9), Robert Bresnahan (3), Bruce Westerman (2).
Across all disclosures, members of Congress reported 12 purchases and 17 sales of Pfizer Inc. (PFE). The most recent trade was on Jul 7, 2026.
Ro Khanna disclosed buying Pfizer Inc. (PFE) on Jul 7, 2026, valued at $1,001 - $15,000.
Tommy Tuberville disclosed selling Pfizer Inc. (PFE) on Jun 8, 2026, valued at $15,001 - $50,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.